Able to distill complex matters into a clear business case and roadmap for execution. Proven track record of achieving or exceeding large-scale, complex short- and long-range strategies in life sciences, Strong track record of cultivating and maintaining strategic relationships and collaborations both internally and externally, Extensive experience interacting with and presenting to executives and managing large-scale project budgets and other resources, Experience working with one or more Gilead therapeutic areas (Virology, Oncology, & Inflammation) and various stages of drug development is strongly preferred. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Executive Director, Executive Assistant, Chief Information Officer and more on Indeed.com Related Searches:All Executive Director Salaries|All Gilead Sciences Salaries. The executive director will play a key role in all stages of development for product programs from the drug discovery stage through product registrations world-wide. Gilead Sciences pays $47.99 an hour, on average. See all Executive Director salaries to learn how this stacks up in the market. Gilead Sciences employees attributed a compensation and benefits rating of 4.3/5 stars to their company. Workers in these departments earn $60,746 and $79,111, respectively. The average salary for a Director is $129,368 per year in United States, which is 64% lower than the average Gilead Sciences salary of $366,353 per year for this job. Has multiple years line management (direct reports) experience. Location: Foster City, CA Change of employer: The estimated additional pay is $229,203 per year. The median salary in Seattle, WA is $108,860. Location: Washington D.C. Additional pay could include bonus, stock, commission, profit sharing or tips. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. How much does a Executive Director at Gilead Sciences make? Chairman and Chief Executive Officer, Gilead Sciences, Inc. Executive Vice President, Pharmaceutical Development and Manufacturing, Executive Vice President, Human Resources, Executive Vice President, Corporate Affairs and General Counsel, Professor, California Institute of Technology, President and Chief Executive Officer, Sonoma Biotherapeutics; A.W. As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Learn about the talented people at Gilead who are working to solve some of the worlds biggest healthcare challenges. The Gilead Leadership Team and Board of Directors provide the necessary guidance to execute our mission and realize our vision. August 09, 2022 - 6 min read, Stories@Gilead - What. For more than 30 years, weve.css-epvm6{white-space:nowrap;} More, Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. https://gilead.inc/3X05coW. 30 days off. Gilead Sciences pays $99,828 a year, on average, or $47.99 an hour. Step-By-Step Pay Equity Analysis Guide Product Guide By clicking Download Product Guide, Do you know what your employees really want for the holidays? In healthcare jobs, the average pay is $115,053. You will provide strategic input and management oversight of commercial regulatory activities across Gilead's product portfolio. Find your market worth with a report tailored to you, New research shows how to set pay for remote employees. Our model gets smarter over time as more people share salaries on Glassdoor. For Current Gilead Employees and Contractors: Please log onto your Internal Career Site (https://www.myworkday.com/gilead/d/inst/13102!CK5mGhIKBggDEMenAhIICgYI1A0QtgI/cacheable-task/2997$2151.htmld#backheader=true) to apply for this job. To create our salary estimates, Zippia starts with data published in publicly available sources such as the U.S. Bureau of Labor Statistics (BLS), Foreign Labor Certification Data Center (FLC). What is the average salary of Gilead Sciences? Employees working in the healthcare department earn a relatively high salary as well, averaging $115,053 per year. We take a deep dive into what's impacting employee retention and what employees are looking for in their new role. Compensation data tools, salary structures, surveys and benchmarks. city, state, country. The estimated base pay is $211,831 per year. The average salaries at Bristol-Myers Squibb rank the highest, with their employees earning an. As we kick off #BlackHistoryMonth, Belinda Moore shares her experience balancing her Patient Support Strategy role while also helping to lead the Gilead Leadership Organization of Black Employees resource group. May 11, 2022 - 4 min read. The base salary for Executive Director of Strategic Product Management in companies like GILEAD SCIENCES, INC. range from $333,450 to $399,190 with the average base salary of $367,240. Global Patient Solutions Our data shows that Gilead Sciences employees in Foster City, CA get paid the most, where the average yearly pay is $115,847. Derilus, Senior Director of Disclosure and Transparency, leads a team that helps build community trust in Gilead and empowers people to make informed decisions about their healthcare. While Gilead Sciences employees earn an average yearly salary of $99,828, different roles can command different wages. Executive Director, Early Clinical Development-Oncology (MD) Gilead Sciences Foster City, CA Just now Be among the first 25 applicants See who Gilead Sciences has hired for this role Join. plus company car. January 17, 2023 - 5 min read, Stories@Gilead - Demonstrates advanced regulatory and business knowledge and advanced analytical abilities, as evidenced by strengths in assessing complex, multidisciplinary data, understanding and effectively advising on regulatory implications. Gilead Sciences pays workers in the bottom 10th percentile under $64,000 a year, while the highest earners in the top 90th percentile make over $153,000. Learn how Belindas career has grown and evolved through various opportunities at Gilead and how she contributes to our efforts to prioritize access, equity, inclusion and diversity. A administrative assistant at Gilead Sciences earns an average yearly salary of $47,443. Other roles at Gilead Sciences include administrative assistant and internship. Executive Director, Chief of Staff to EVP Corporate Affairs & General Counsel United States - California - Foster City Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. , Joined Gilead: April 2018. The average Gilead Sciences hourly pay ranges from approximately $25 per hour for an Intern - Hourly to $112 per hour for an Associate Director. Be part of Gilead's journey as we strive to solve some of the world's biggest healthcare challenges today. A person is considered fully vaccinated two weeks after the second dose of a two-dose vaccine or two weeks after a single-dose vaccine has been administered. The starting pay at Gilead Sciences is $64,000 per year, or $30.77 per hour. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Skip to Main Content. Gilead Sciences may also be known as or be related to Gilead Sciences, Gilead Sciences Foundation, Gilead Sciences Inc and Gilead Sciences, Inc. Gilead Jobs. The salary range for an Executive Assistant To Managing Director job is from $50,844 to $71,755 per year in Mount Gilead, OH. that oversees more junior Executive Directors, this experience can increase the likelihood to earn more. It allowes employees to manage their work-life balance, Decent life insurance package for employees , At Gilead, were committed to creating a healthier world for everyone no matter the challenges ahead of us. June 22, 2022 - 1 min read, Stories@Gilead - Indication for Follicular Lymphoma and Small Lymphocytic Leukemia, Veklury (Remdesivir) Receives Positive CHMP Opinion for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression, Gilead Issues a Voluntary Nationwide Recall of Two Lots of Veklury (Remdesivir) Due to Presence of Glass Particulates, Gilead Statement on Veklury (Remdesivir) and the SARS-CoV-2 Omicron Variant, Gilead and Merck Announce Temporary Pause in Enrollment for Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Islatravir and Investigational Lenacapavir, Gilead Announces Decision Not to Pursue Marketing Authorization for Descovy for Pre-Exposure Prophylaxis in the European Union, Gilead Statement on New NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Recommendation for Sacituzumab Govitecan-Hziy (Trodelvy) in Second-Line and Later Metastatic Triple-Negative Breast Cancer, Gilead Sciences Statement on Requiring Vaccination Against COVID-19 for Employees, Gilead Warns of Counterfeit HIV Medication Being Distributed in the United States, Gilead Sciences Statement on Positive Phase 3 AMBITION Study Findings for the Treatment of HIV-Associated Cryptococcal Meningitis, Gilead Sciences Response to Open Letter Regarding Access to AmBisome (liposomal amphotericin B), Gilead Statement on New England Journal of Medicine Publication of Positive Phase 3 ASCENT Study of Trodelvy in Metastatic Triple-Negative Breast Cancer, Gilead Sciences Statement on Phase 3 Veklury (Remdesivir) Intravenous Study in High Risk Non-Hospitalized Patients with COVID-19, Gilead Announces Additional Updates to The Advancing ACCESS Patient Assistance/Medication Assistance Program, Gilead Announces Updates to The Advancing ACCESS Patient Assistance/Medication Assistance Program, Gilead Announces Plans for New Location in North Carolinas Research Triangle Region Dedicated to Business Services, Gilead Sciences Statement on the Passing of the Honorable George P. Shultz, PhD. Great health insurance options but cost is high, 5 weeks which include 2 weeks mandatory shutdown, Max 15k contribution. That works out to $62 per hour at Gilead Sciences, compared to $125 per hour at Genentech. Indication for Follicular Lymphoma and Small Lymphocytic Leukemia, Veklury (Remdesivir) Receives Positive CHMP Opinion for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression, Gilead Issues a Voluntary Nationwide Recall of Two Lots of Veklury (Remdesivir) Due to Presence of Glass Particulates, Gilead Statement on Veklury (Remdesivir) and the SARS-CoV-2 Omicron Variant, Gilead and Merck Announce Temporary Pause in Enrollment for Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Islatravir and Investigational Lenacapavir, Gilead Announces Decision Not to Pursue Marketing Authorization for Descovy for Pre-Exposure Prophylaxis in the European Union, Gilead Statement on New NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Recommendation for Sacituzumab Govitecan-Hziy (Trodelvy) in Second-Line and Later Metastatic Triple-Negative Breast Cancer, Gilead Sciences Statement on Requiring Vaccination Against COVID-19 for Employees, Gilead Warns of Counterfeit HIV Medication Being Distributed in the United States, Gilead Sciences Statement on Positive Phase 3 AMBITION Study Findings for the Treatment of HIV-Associated Cryptococcal Meningitis, Gilead Sciences Response to Open Letter Regarding Access to AmBisome (liposomal amphotericin B), Gilead Statement on New England Journal of Medicine Publication of Positive Phase 3 ASCENT Study of Trodelvy in Metastatic Triple-Negative Breast Cancer, Gilead Sciences Statement on Phase 3 Veklury (Remdesivir) Intravenous Study in High Risk Non-Hospitalized Patients with COVID-19, Gilead Announces Additional Updates to The Advancing ACCESS Patient Assistance/Medication Assistance Program, Gilead Announces Updates to The Advancing ACCESS Patient Assistance/Medication Assistance Program, Gilead Announces Plans for New Location in North Carolinas Research Triangle Region Dedicated to Business Services, Gilead Sciences Statement on the Passing of the Honorable George P. Shultz, PhD. The estimated additional pay is $170,828 per year. New research on who's asking for raises and who's getting them as well as advice on how to ensure you're getting the salary you deserve. Max annual salary up to a maximum of 140.000 based on full-time (depending on work experience and expertise). Salary information comes from 9 data points collected directly from employees, users, and past and present job advertisements on Indeed in the past 36 months. Home View All Jobs (952) Job Information. This estimate is based upon 2 Gilead Sciences Executive Director salary report (s) provided by employees or estimated based upon statistical methods. Gilead is driven by our purpose of making the world a healthier place for all people and we do it by delivering innovative therapies, improving access to our medicines and helping remedy health inequities and other barriers to care. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Were looking forward to more meaningful conversations throughout the month. There may be multiple reasons for pay differences - one of which is a small number of salaries submitted per job. If you want to compare the executive directors salaries between Gilead Sciences and some similar companies, being employed by a company such as Genentech or Abbott would be a smart choice, as they are the highest-paying companies in this field. For more than 30 years, weve.css-epvm6{white-space:nowrap;}.css-epvm6{white-space:nowrap;} More, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips, A Guide to Negotiating the Salary You Deserve, How to Prepare for Your Interview and Land the Job. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. Toward Health Equity for Black People Impacted by TNBC, Christi Shaw to Depart Gilead and Kite Leadership End of Q1, Gilead Sciences Commends Convictions in Counterfeiting Scheme Pledges Continued Commitment to Protect Patients, Gilead Enables Easier Veklury (Remdesivir) Access Through Retail and Specialty Pharmacies for Long-Term Care and Skilled Nursing Facilities, Gilead Receives Complete Response Letter from U.S. FDA for Bulevirtide for the Treatment of Adults with Hepatitis Delta Virus, Gilead Continues Efforts to Halt the Distribution of Counterfeit HIV Medications and Protect Patient Safety, Veklury (Remdesivir) Demonstrates Continued In Vitro Antiviral Activity Against Omicron Subvariants, Including BA.4 and BA.5, Sacituzumab Govitecan-Hziy Trodelvy Elevated to Category 1 Preferred Recommendation in Second-Line Metastatic Triple-Negative Breast Cancer, Gilead Sciences Statement on FDA Acceptance of New Drug Application for Investigational Lenacapavir, Gilead Statement on U.S. Supreme Court Overturning Roe v. Wade.
Apartments In Howard, Wi,
Federal Hiring Process Tentative Offer,
Articles E